Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 190, Issue 3, Pages 571-579Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/422259
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI-20624, AI-25011] Funding Source: Medline
- ODCDC CDC HHS [CCU618387] Funding Source: Medline
Ask authors/readers for more resources
Staphylococcus aureus can cause a variety of acute and chronic diseases. The ability of S. aureus to cause persistent infections has been linked to its ability to evade or inactivate host immune responses. We have identified a secreted 19-kDa protein produced by S. aureus that binds to the complement protein C3. N-terminal sequencing of this protein identified it as the extracellular fibrinogen-binding protein (Efb). In this study, we demonstrate that Efb can bind to the alpha-chain of C3 and inhibit both the classical and alternative pathways of complement activation. In addition, we show that Efb can inhibit complement-mediated opsonophagocytosis in a dose-dependent manner and that Efb inhibits complement activity by blocking deposition of C3 or by preventing further complement activation beyond C3b. These data suggest that Efb is a virulence factor involved in facilitating persistent S. aureus infections by interfering with complement activity in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available